BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29142128)

  • 1. Interaction between a Unique Minor Protein and a Major Capsid Protein of Bluetongue Virus Controls Virus Infectivity.
    Matsuo E; Yamazaki K; Tsuruta H; Roy P
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Interaction of Bluetongue Virus VP6 and Genomic RNA Is Essential for Genome Packaging.
    Sung PY; Vaughan R; Rahman SK; Yi G; Kerviel A; Kao CC; Roy P
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA genome packaging and capsid assembly of bluetongue virus visualized in host cells.
    Xia X; Sung PY; Martynowycz MW; Gonen T; Roy P; Zhou ZH
    Cell; 2024 Apr; 187(9):2236-2249.e17. PubMed ID: 38614100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro reconstitution of Bluetongue virus infectious cores.
    Lourenco S; Roy P
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13746-51. PubMed ID: 21808007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure based modification of Bluetongue virus helicase protein VP6 to produce a viable VP6-truncated BTV.
    Matsuo E; Leon E; Matthews SJ; Roy P
    Biochem Biophys Res Commun; 2014 Sep; 451(4):603-8. PubMed ID: 25128829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bluetongue virus assembly and exit pathways.
    Roy P
    Adv Virus Res; 2020; 108():249-273. PubMed ID: 33837718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of bluetongue virus VP6 protein as a nucleic acid-binding protein and the localization of VP6 in virus-infected vertebrate cells.
    Roy P; Adachi A; Urakawa T; Booth TF; Thomas CP
    J Virol; 1990 Jan; 64(1):1-8. PubMed ID: 2152806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV).
    van Rijn PA; van de Water SG; Feenstra F; van Gennip RG
    Virol J; 2016 Jul; 13():119. PubMed ID: 27368544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA Origami: Packaging a Segmented Genome in Orbivirus Assembly and Replication.
    Sung PY; Roy P
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of domains in bluetongue virus VP3 molecules essential for the assembly of virus cores.
    Tanaka S; Roy P
    J Virol; 1994 May; 68(5):2795-802. PubMed ID: 8151751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified recombinant bluetongue virus VP1 exhibits RNA replicase activity.
    Boyce M; Wehrfritz J; Noad R; Roy P
    J Virol; 2004 Apr; 78(8):3994-4002. PubMed ID: 15047815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential packaging of RNA genomic segments during the assembly of Bluetongue virus.
    Sung PY; Roy P
    Nucleic Acids Res; 2014 Dec; 42(22):13824-38. PubMed ID: 25428366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.
    Celma CC; Stewart M; Wernike K; Eschbaumer M; Gonzalez-Molleda L; Breard E; Schulz C; Hoffmann B; Haegeman A; De Clercq K; Zientara S; van Rijn PA; Beer M; Roy P
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic Acid Binding Sites in VP2 of Bluetongue Virus and Their Use during Virus Entry.
    Wu W; Roy P
    J Virol; 2022 Jan; 96(1):e0167721. PubMed ID: 34669428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formation.
    Matsuo E; Roy P
    J Virol; 2009 Sep; 83(17):8842-8. PubMed ID: 19553329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly and intracellular localization of the bluetongue virus core protein VP3.
    Kar AK; Iwatani N; Roy P
    J Virol; 2005 Sep; 79(17):11487-95. PubMed ID: 16103199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topography and immunogenicity of bluetongue virus VP7 epitopes.
    Wang LF; Hyatt AD; Whiteley PL; Andrew M; Li JK; Eaton BT
    Arch Virol; 1996; 141(1):111-23. PubMed ID: 8629938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baculovirus multigene expression vectors and their use for understanding the assembly process of architecturally complex virus particles.
    Roy P; Mikhailov M; Bishop DH
    Gene; 1997 Apr; 190(1):119-29. PubMed ID: 9185857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reverse genetics systems for orbiviruses reveal the essential mechanisms in their replication].
    Matsuo E
    Uirusu; 2014; 64(2):203-12. PubMed ID: 26437842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.